# Akili Inc. (AKLI)

Source: https://www.quantisnow.com/company/AKLI
Generated: 2026-11-17T15:23:14.246Z

- Ticker: AKLI
- Exchange: NASDAQ
- Sector: Health Care
- Industry: Medical/Dental Instruments
- IPO year: 2021

## Latest AKLI news and filings

- 2024-08-28 06:01 UTC [Earnings Date] [PureTech Health plc – Half-Year Report](https://www.quantisnow.com/insight/puretech-health-plc-half-year-report-5674041)
- 2024-07-12 21:16 UTC [SEC Form 15-12G filed by Akili Inc.](https://www.quantisnow.com/insight/sec-form-15-12g-filed-by-akili-inc-5606787)
- 2024-07-10 04:15 UTC [SEC Form EFFECT] [SEC Form EFFECT filed by Akili Inc.](https://www.quantisnow.com/insight/sec-form-effect-filed-by-akili-inc-5600654)
- 2024-07-09 12:05 UTC [SEC Schedule 13D] [Amendment: SEC Form SC 13D/A filed by Akili Inc.](https://www.quantisnow.com/insight/amendment-sec-form-sc-13da-filed-by-akili-inc-5598756)
- 2024-07-08 23:42 UTC [SEC Form 4] [SEC Form 4 filed by Large owner Puretech Health Plc](https://www.quantisnow.com/insight/sec-form-4-filed-by-large-owner-puretech-health-plc-5598097)
- 2024-07-05 21:36 UTC [SEC Form 4] [SEC Form 4 filed by Large owner Palihapitiya Chamath](https://www.quantisnow.com/insight/sec-form-4-filed-by-large-owner-palihapitiya-chamath-5595802)
- 2024-07-05 21:36 UTC [SEC Schedule 13D] [Amendment: SEC Form SC 13D/A filed by Akili Inc.](https://www.quantisnow.com/insight/amendment-sec-form-sc-13da-filed-by-akili-inc-5595800)
- 2024-07-05 16:05 UTC [SEC Schedule 13G] [Amendment: SEC Form SC 13G/A filed by Akili Inc.](https://www.quantisnow.com/insight/amendment-sec-form-sc-13ga-filed-by-akili-inc-5595225)
- 2024-07-05 15:54 UTC [SEC Form 4] [SEC Form 4 filed by Large owner Temasek Holdings (Private) Ltd](https://www.quantisnow.com/insight/sec-form-4-filed-by-large-owner-temasek-holdings-private-5595205)
- 2024-07-02 14:32 UTC [SEC Form 4] [President & CEO Franklin Matthew returned 33,000 shares to the company, closing all direct ownership in the company (SEC Form 4)](https://www.quantisnow.com/insight/president-ceo-franklin-matthew-returned-33000-shares-to-the-company-5588823)
- 2024-07-02 14:31 UTC [SEC Form 4] [Chief Legal Officer Studer Jacqueline returned 92,869 shares to the company, closing all direct ownership in the company (SEC Form 4)](https://www.quantisnow.com/insight/chief-legal-officer-studer-jacqueline-returned-92869-shares-to-the-5588822)
- 2024-07-02 14:29 UTC [SEC Form 4] [Director Martucci Walter Edward Ii returned 99,548 shares to the company, closing all direct ownership in the company (SEC Form 4)](https://www.quantisnow.com/insight/director-martucci-walter-edward-ii-returned-99548-shares-to-the-5588812)
- 2024-07-02 14:29 UTC [SEC Form 4] [SEC Form 4 filed by Director Spinale John](https://www.quantisnow.com/insight/sec-form-4-filed-by-director-spinale-john-5588811)
- 2024-07-02 14:28 UTC [SEC Form 4] [Director Gazzaley Adam closing all direct ownership in the company (SEC Form 4)](https://www.quantisnow.com/insight/director-gazzaley-adam-closing-all-direct-ownership-in-the-company-5588808)
- 2024-07-02 14:00 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Akili Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-akili-inc-5588752)
- 2024-07-02 13:59 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Akili Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-akili-inc-5588751)
- 2024-07-02 13:57 UTC [SEC Form POS AM filed by Akili Inc.](https://www.quantisnow.com/insight/sec-form-pos-am-filed-by-akili-inc-5588733)
- 2024-07-02 13:55 UTC [SEC Form 8-K] [Akili Inc. filed SEC Form 8-K: Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Changes in Control of Registrant, Leadership Update, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Other Events, Financial Statements and Exhibits](https://www.quantisnow.com/insight/akili-inc-filed-sec-form-8-k-completion-of-acquisition-or-5588729)
- 2024-07-02 13:53 UTC [SEC Schedule 14D-9] [Amendment: SEC Form SC 14D9/A filed by Akili Inc.](https://www.quantisnow.com/insight/amendment-sec-form-sc-14d9a-filed-by-akili-inc-5588724)
- 2024-07-02 13:52 UTC [SEC Form 25-NSE filed by Akili Inc.](https://www.quantisnow.com/insight/sec-form-25-nse-filed-by-akili-inc-5588722)
- 2024-07-02 11:19 UTC [Virtual Therapeutics Announces Results of Tender Offer to Acquire Akili Interactive](https://www.quantisnow.com/insight/virtual-therapeutics-announces-results-of-tender-offer-to-acquire-akili-5588147)
- 2024-06-18 20:09 UTC [SEC Form 8-K] [SEC Form 8-K filed by Akili Inc.](https://www.quantisnow.com/insight/sec-form-8-k-filed-by-akili-inc-5565091)
- 2024-06-18 20:09 UTC [Market Chatter] [Akili Says EndeavorOTC Is The Only FDA-Authorized Digital Therapeutic For ADHD Available Without A Prescription](https://www.quantisnow.com/insight/akili-says-endeavorotc-is-the-only-fda-authorized-digital-therapeutic-for-5565081)
- 2024-06-18 20:02 UTC [Market Chatter] [Akili Reports FDA Clearance Of EndeavorOTC (AKL-T01) As An Over-the-counter Treatment For Adults With Attention-deficit/Hyperactivity Disorder](https://www.quantisnow.com/insight/akili-reports-fda-clearance-of-endeavorotc-akl-t01-as-an-over-the-counter-5564948)
- 2024-06-18 20:01 UTC [Akili Announces FDA Authorization of EndeavorOTC, the First FDA Clearance of a Digital Treatment for Adults with ADHD Through a Video Game](https://www.quantisnow.com/insight/akili-announces-fda-authorization-of-endeavorotc-the-first-fda-clearance-5564929)
- 2024-06-11 21:38 UTC [SEC Form 4] [Chief Legal Officer Studer Jacqueline covered exercise/tax liability with 5,118 shares, decreasing direct ownership by 1% to 408,212 units (SEC Form 4)](https://www.quantisnow.com/insight/chief-legal-officer-studer-jacqueline-covered-exercisetax-liability-with-5118-5551962)
- 2024-06-10 20:56 UTC [SEC Schedule 13G] [SEC Form SC 13G filed by Akili Inc.](https://www.quantisnow.com/insight/sec-form-sc-13g-filed-by-akili-inc-5548992)
- 2024-05-31 20:30 UTC [SEC Schedule 13D] [SEC Form SC 13D/A filed by Akili Inc. (Amendment)](https://www.quantisnow.com/insight/sec-form-sc-13da-filed-by-akili-inc-amendment-5529813)
- 2024-05-30 12:05 UTC [SEC Schedule 13D] [SEC Form SC 13D/A filed by Akili Inc. (Amendment)](https://www.quantisnow.com/insight/sec-form-sc-13da-filed-by-akili-inc-amendment-5524904)
- 2024-05-29 20:05 UTC [SEC Form SC14D9C filed by Akili Inc.](https://www.quantisnow.com/insight/sec-form-sc14d9c-filed-by-akili-inc-5523105)
- 2024-05-29 13:16 UTC [SEC Form SC14D9C filed by Akili Inc.](https://www.quantisnow.com/insight/sec-form-sc14d9c-filed-by-akili-inc-5522273)
- 2024-05-29 13:14 UTC [SEC Form 8-K] [Akili Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits](https://www.quantisnow.com/insight/akili-inc-filed-sec-form-8-k-entry-into-a-material-5522266)
- 2024-05-29 12:25 UTC [Market Chatter] [Trading Halt: Halt status updated at 8:25:00 AM ET: Quotation Resumption: News and Resumption Times](https://www.quantisnow.com/insight/trading-halt-halt-status-updated-at-82500-am-et-quotation-5522028)
- 2024-05-29 12:11 UTC [Market Chatter] [PureTech Health Announces Merger Agreement Between Akili and Virtual Therapeutics to Form Leading Digital Health Company](https://www.quantisnow.com/insight/puretech-health-announces-merger-agreement-between-akili-and-virtual-therapeutics-5521993)
- 2024-05-29 12:09 UTC [PureTech Founded Entity Akili Interactive and Virtual Therapeutics Announce Entering Into Definitive Merger Agreement to Establish Leading Digital Health Company](https://www.quantisnow.com/insight/puretech-founded-entity-akili-interactive-and-virtual-therapeutics-announce-entering-5521980)
- 2024-05-29 12:00 UTC [Virtual Therapeutics, Akili Interactive Enter Into Definitive Merger Agreement to Establish Leading Digital Health Company](https://www.quantisnow.com/insight/virtual-therapeutics-akili-interactive-enter-into-definitive-merger-agreement-to-5521925)
- 2024-05-29 11:57 UTC [Market Chatter] [Trading Halt: Halted at 7:57:37 a.m. ET - Trading Halt: Halt News Pending](https://www.quantisnow.com/insight/trading-halt-halted-at-75737-am-et---trading-halt-5521851)
- 2024-05-14 20:41 UTC [Market Chatter] [Akili Q1 2024 Adj EPS $(0.12) Beats $(0.14) Estimate, Sales $383.00K Miss $794.00K Estimate](https://www.quantisnow.com/insight/akili-q1-2024-adj-eps-012-beats-014-estimate-sales-5489834)
- 2024-05-14 20:31 UTC [Market Insight] [12 Health Care Stocks Moving In Tuesday's After-Market Session](https://www.quantisnow.com/insight/12-health-care-stocks-moving-in-tuesdays-after-market-session-5489632)
- 2024-05-14 20:24 UTC [Market Chatter] [Akili Evaluates Potential Strategic Alternatives](https://www.quantisnow.com/insight/akili-evaluates-potential-strategic-alternatives-5489515)

## More

- Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/AKLI
- Earnings history: https://www.quantisnow.com/earnings/AKLI
- Dividend history: https://www.quantisnow.com/dividends/AKLI
- Insider transactions: https://www.quantisnow.com/insiders/AKLI
- Options chain: https://www.quantisnow.com/options/AKLI
- SEC 8-K filings only: https://www.quantisnow.com/company/AKLI/8-k
- RSS and alerts for AKLI: https://www.quantisnow.com/docs/rss-feeds.md
